Supplemental Figure 5 from Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor

MLA

Ronald P. DeMatteo, et al. Supplemental Figure 5 from Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22464077.

APA

Ronald P. DeMatteo, Justin R. Cross, Vinod P. Balachandran, Cristina R. Antonescu, Ferdinand Rossi, Julia N. Zhao, Alec J. Moral, Mengyuan Liu, Nesteene J. Param, Jennifer K. Loo, Jennifer Q. Zhang, Timothy G. Bowler, Shan Zeng, Benjamin D. Medina, & Gerardo A. Vitiello. (2023). Supplemental Figure 5 from Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor. https://doi.org/10.1158/1078-0432.22464077

Chicago

Ronald P. DeMatteo, Justin R. Cross, Vinod P. Balachandran, Cristina R. Antonescu, Ferdinand Rossi, Julia N. Zhao, Alec J. Moral, et al. 2023. “Supplemental Figure 5 from Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor,” March. doi:10.1158/1078-0432.22464077.